Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Impel Pharmaceuticals
Impel Pharmaceuticals
(IMPL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Trudhesa
Dihydroergotamine
2021-09-02
2032-2039
Migraine disorders
,
Orthostatic hypotension
,
Cluster headache
,
Postpartum hemorrhage
,
Xerostomia
,
Myocardial infarction
,
Pulmonary embolism
,
Postoperative complications
,
Pain
,
Thromboembolism
,
Cerebral infarction
,
Ventricular tachycardia
,
Coronary thrombosis
,
Unstable angina
,
Cardiac arrhythmias
,
Burns
,
Esophageal diseases
,
Thrombophlebitis
,
Ventricular fibrillation
,
Ventricular premature complexes
,
Mouth diseases
,
Paroxysmal tachycardia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Dihydroergotamine
migraine disorders
Benzodiazepine
healthy volunteers/patients
,
type 2 diabetes mellitus
,
melanoma
,
overweight
,
neoplasms
,
non-small-cell lung carcinoma
,
obesity
,
respiratory syncytial virus infections
,
brain neoplasms
,
central nervous system neoplasms
,
brain diseases
,
glucose metabolism disorders
,
metabolic diseases
,
alzheimer disease
,
huntington disease
,
thyroid neoplasms
,
glioma
,
sickle cell anemia
,
atopic dermatitis
,
colorectal neoplasms
,
anxiety disorders
,
prostatic neoplasms
,
breast neoplasms
,
liposarcoma
,
adenocarcinoma of lung
,
generalized anxiety disorder
,
reflex epilepsy
,
bipolar disorder
,
diabetes mellitus
,
epilepsy
,
status epilepticus
,
critical illness
,
delirium
,
psychomotor agitation
,
post-traumatic stress disorders
,
executive function
,
seizures
,
partial epilepsies
,
generalized epilepsy
,
complex partial epilepsy
,
schizophrenia
,
insulin resistance
,
metabolic syndrome
,
syndrome
,
major depressive disorder
,
depressive disorder
,
psychotic disorders
,
gastrointestinal endoscopy
,
hyperlipidemias
,
hyperglycemia
Benserazide
schizotypal personality disorder
,
sickle cell anemia
,
beta-thalassemia
,
thalassemia
,
ischemic stroke
,
stroke
,
restless legs syndrome
,
parkinson disease
,
healthy volunteers/patients
,
retinal diseases
,
treatment adherence and compliance
,
aphasia
,
menstrual cycle
,
periodontal diseases
,
inflammation
,
periodontitis
Phenylalanine
plasmacytoma
,
multiple myeloma
,
plasma cell neoplasms
,
melanoma
,
parkinson disease
Bevifimod
amyotrophic lateral sclerosis
,
motor neuron disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use